Functional antagonistic activity of Rec 15/2739, a novel alpha-1 antagonist selective for the lower urinary tract, on noradrenaline-induced contraction of human prostate and mesenteric artery

Journal of Pharmacology and Experimental Therapeutics

Volumn 277, Issue 3, 1996, Pages 1237-1246

  Testa, Rodolfo ^a   Guarneri, Luciano ^a   Taddei, Carlo ^a   Poggesi, Elena ^a   Angelico, Patrizia ^a   Sartani, Abraham ^a   Leonardi, Amedeo ^a   Gofrit, Ofer N ^b   Meretyk, Shimon ^b   Caine, Marco ^b  

^a Recordati SpA   (Italy)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

5 METHYLURAPIDIL; 8 [3 [4 (2 HYDROXYPHENYL) 1 PIPERAZINYL]PROPYLCARBAMOYL] 3 METHYLFLAVONE; 8 [3 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]PROPYLCARBAMOYL] 3 METHYLFLAVONE; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 1B ADRENERGIC RECEPTOR; ALPHA 1D ADRENERGIC RECEPTOR; CHLOROETHYLCLONIDINE; NIFEDIPINE; NORADRENALIN; PRAZOSIN; REC 15 2636; REC 15 2667; REC 15 2816; REC 15 2841; TAMSULOSIN; TERAZOSIN; UNCLASSIFIED DRUG;

ARTERY CONSTRICTION; ARTICLE; DRUG EFFECT; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SCREENING; DRUG STRUCTURE; HUMAN; HUMAN TISSUE; MALE; MESENTERIC ARTERY; PRIORITY JOURNAL; PROSTATE; RECEPTOR AFFINITY; URETHRA;

ANIMALS; CHROMONES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; KINETICS; MALE; MESENTERIC ARTERIES; MUSCLE CONTRACTION; NOREPINEPHRINE; PROSTATE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-1; URINARY TRACT;

EID: 12644310322     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. AALKJAER, C., HEAGERTY, A. M., PETERSEN, K. K., SWALES, J. D. AND MULVANY, M. J.: Evidence for increased media thickness, increased neuronal amine uptake, and depressed excitation-contraction coupling in isolated resistance vessels from essential hypertensives. Circ. Res. 61: 181-186, 1987.
2. 1-adrenoceptors. Eur. J. Pharmacol. 172: 131-145, 1989.
3. CAINE, M. AND PERLBERG, S.: Dynamics of acute retention in prostatic patients and role of adrenergic receptors. Urology 9: 399-403, 1977.
4. CAINE, M.: Alpha-adrenergic blockers for the treatment of benign prostatic hypertrophy. Urol. Clin. North Amer. 17: 641-649, 1990.
5. CAINE, M., PFAU, A. AND PERLBERG, S.: The use of alpha-adrenergic blockers in benign prostatic obstruction. Br. J. Urol. 48: 255-263, 1976.
6. 1-adrenoceptor subtypes in the human prostate. Br. J. Urol. 74: 585-589, 1994.
7. 50) of an enzyme reaction. Biochem. Pharmacol. 22: 3099-3108, 1973.
8. 1-adrenoceptor classification scheme. Pharmacol. Comm. 6: 9-14, 1995.
9. 1-adrenoceptor. Proc. Natl. Acad. Sci. U.S.A. 85: 7159-7163, 1988.
10. DE LEAN, A., MUNSON, P. J. AND RODBARD, D.: Simultaneous analysis of families of sigmoidal curves: Application to bioassay, radioligand assay, and physiological dose-response curves. Am. J. Physiol. 235: E97-E102, 1978.
11. FAWZY, A., BRAUN, K., LEWIS, G. P., GAFFNEY, M., ICE, K. AND DIAS, N.: Doxazosin in the treatment of benign prostatic hyperplasia in normotensive patients: A multicenter study. J. Urol. 154: 105-109, 1995.
12. FLAVAHAN, N. A., COOKE, J. P., SHEPHERD, J. T. AND VANHOUTTE, P. M.: Human postjunctional alpha-1 and alpha-2 adrenoceptors: Differential distribution in arteries of the limbs. J. Pharmacol. Exp. Ther. 241: 361-365, 1987.
13. 1-Adrenoceptor subclassification in vascular smooth muscle. Trends Pharmacol. Sci. 7: 347-349, 1986.
14. 1A adrenoceptor antagonist, RS 17053. Br. J. Pharmacol. 114: 24P, 1995.
15. 1-Adrenoceptor classification: Sharpening Occam's razor. Trends Pharmacol. Sci. 15: 167-170, 1994.
16. 1c subtype. Mol. Pharmacol. 45: 703-708, 1994a.
17. 1c adrenergic receptor antagonists on the contraction of human prostatic smooth muscle. J. Urol. 151: 267A, 1994b.
18. GLUSA, E. AND MARKWARDT, F.: Characterization of postjunctional α-adrenoceptors in isolated human femoral veins and arteries. Naunyn-Schmiedeberg's Arch. Pharmacol. 323: 101-105, 1983.
19. 1-adrenoceptor. Eur. J. Pharmacol. 151: 333-335, 1988.
20. 1-adrenoceptor subtypes in tension response of human prostate to electrical field stimulation. Br. J. Pharmacol. 115: 142-146, 1995.
21. GUH, D. I., SHAPIRO, E., BAUMANN, M. AND LEPOR, H.: Autonomic receptors in human prostatic adenomas. J. Urol. 143: 179-185, 1990.
22. 2+ in smooth muscle. Nature (Lond.) 329: 333-335, 1987.
23. HIEBLE, J. P., CAINE, M. AND ZALAZNIK, E.: In vitro characterization of the α-adrenoceptors in human prostate. Eur. J. Pharmacol. 107: 111-117, 1985.
24. HIEBLE, J. P., BOYCE, A. J. AND CAINE, M.: Comparison of the α-adrenoceptor characteristics in human and canine prostate. Fed. Proc. 45: 2609-2614, 1986.
25. 1-adrenoceptors: Consensus update. Pharmacol. Rev. 47: 267-270, 1995.
26. 1-Adrenoceptor subtype mediating contraction of the smooth muscle in the lower urinary tract and prostate of rabbits. Naunyn-Schmiedeberg's Arch. Pharmacol. 330: 16-21, 1985.
27. 1D-adrenoceptor mediating the contractile response of rat aorta to noradrenaline. Br. J. Pharmacol. 115: 981-986, 1995.
28. 1-adrenoceptor antagonists on prostatic pressure and blood pressure in the anesthetized dog. Urology 44: 52-57, 1994.
29. 1A subtype. Mol. Pharmacol. 46: 414-422, 1994.
30. LEONARDI, A., MOTTA, G., RIVA, C. AND TESTA, R.: Derivati benzopiranici e benzotiopiranici. IT patent MI92A000408, U.S. application 888775, 1992.
31. LEPOR, H., AUERBACH, S., PURAS-BAEZ, A., NARAYAN, P., SOLOWAY, M., LOWE, F., MOON, T., LEIFER, G. AND MADSEN, P. J.: A randomized, placebo-controlled multicenter study of the efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia. J. Urol. 148: 1467-1474, 1992.
32. 1 adrenoceptor subtypes in the human prostate. J. Urol. 149: 640-642, 1993.
33. 1A-adrenoceptor: The gene for which is located on human chromosome 5. J. Biol. Chem. 266: 6365-6369, 1991.
34. 1C-adrenoceptor: Functional characterization in prostate. Br. J. Pharmacol, 107: 327P, 1992.
35. 1-adrenoceptor subtypes. Naunyn-Schimiedeberg's Arch. Pharmacol. 350: 136-142, 1994.
36. 1A-Adrenergic receptors in the isolated human prostate. Pharmacol. Comm. 4: 181-188, 1994.
37. 1-adrenoceptor subtypes in dog mesenteric and carotid arteries and rabbit carotid arteries. Br. J. Pharmacol. 102: 210-214, 1991.
38. 1-adrenoceptors in vascular smooth muscle. Br. J. Pharmacol. 99: 197-201, 1990.
39. 1-adrenoceptor subtypes in the human prostate: Functional and binding studies. Br. J. Urol. 74: 572-578, 1994.
40. 1-adrenoceptors. Phannacol. Comm. 6: 23-28, 1995.
41. 1-adrenoceptor subtypes. Br. J. Pharmacol. 114: 26P, 1995.
42. 1-Adrenoceptor subtypes in rabbit thoracic aorta. Jpn. J. Pharmacol. 58:suppl. II, 276P, 1992.
43. 1D-adrenergic receptor. Mol. Pharmacol. 40: 876-883, 1991.
44. 1A-subtype? FASEB J. 8: A353, 1994.
45. 1 adrenergic receptor subtypes in human prostate. J. Urol. 150: 546-551, 1993.
46. RAZ, S., ZEIGLER, M. AND CAINE, M.: Pharmacological receptors in the prostate. Br. J. Urol. 45: 663-667, 1973.
47. 1D-subtype. Can. J. Physiol. Pharmacol. 72:suppl. I; A323, 1994.
48. 1-adrenoceptor subtype. J. Biol. Chem. 265: 8183-8189, 1990.
49. 1-adrenergic receptors: Sequence corrections and direct comparison with other species homologues. J. Pharmacol. Exp. Ther. 272: 134-142, 1995.
50. 3H]rauwolscine. J. Urol. 136: 1038-1042, 1986.
51. 1-adrenoceptors of canine prostate. FASEB J. 6: A1021, 1992.
52. 1-Adrenoceptor subtypes in the bovine prostate and human benign prostatic hypertrophy. J. Urol. 149: 241A, 1993.
53. TANG, R., LEPOR, H., SHAPIRO, E., FORRAY, C., WETZEL, J. AND GLUCHOWSKY, C.: Localization of α-1c adrenoceptors in human prostatic tissue. FASEB J. 8: A875, 1994.
54. 1D-adrenoceptor subtype is involved in the noradrenaline-induced contractions of rat aorta. Life Sci. 57: PL159-PL163, 1995a.
55. 1-adrenoceptor subtypes in prostate and prostatic urethra of rat, rabbit, dog and man. Eur. J. Pharmacol. 249: 307-315, 1993.
56. 1-antagonist selective for the lower urinary tract: In vivo studies. Neurourol. Urodyn. 13: 471-473, 1994.
57. 1-adrenoceptor antagonist. Pharmacol. Comm. 6: 79-86, 1995b.
58. TODA, N.: Isolated human coronary arteries in response to vasoconstrictor substances. Am. J. Physiol. 245 (Heart Circ. Physiol. 14): H937-H941, 1983.
59. 1-adrenoceptor subtype affinities. Br. J. Pharmacol. 116: 208P, 1995.
60. 1-adrenoceptor antagonist binding in human prostate and aorta. Clin. Exp. Pharmacol. Physiol. 21: 405-411, 1994.
61. YAMANAKA, N., YAMAGUCHI, O., KAMEOKA, H., FUKAYA, Y., YOKATA, T. AND SHIRAIWA, Y.: Effect of KT-611 (naftopidil) on the contraction of human prostatic tissue and its use in benign prostatic obstruction. Acta Urol. Jpn. 37: 1759-1772, 1991.
62. 1-adrenoceptor antagonist on human hyperplastic prostates. Eur. J. Pharmacol. 252: 29-34, 1994.